Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022

SELL
$88.02 - $127.79 $3.73 Million - $5.42 Million
-42,427 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$122.75 - $162.68 $6.41 Million - $8.49 Million
-52,200 Reduced 55.16%
42,427 $5.45 Million
Q2 2021

Jul 23, 2021

SELL
$105.76 - $154.96 $1.52 Million - $2.23 Million
-14,386 Reduced 13.2%
94,627 $14.4 Million
Q1 2021

May 05, 2021

SELL
$78.5 - $126.48 $1.95 Million - $3.14 Million
-24,811 Reduced 18.54%
109,013 $11.5 Million
Q4 2020

Feb 02, 2021

SELL
$55.93 - $82.78 $2.13 Million - $3.15 Million
-37,996 Reduced 22.11%
133,824 $10.6 Million
Q3 2020

Oct 30, 2020

SELL
$45.65 - $61.81 $1.61 Million - $2.19 Million
-35,354 Reduced 17.06%
171,820 $9.72 Million
Q2 2020

Aug 05, 2020

SELL
$29.15 - $61.54 $991 - $2,092
-34 Reduced 0.02%
207,174 $12.7 Million
Q1 2020

May 05, 2020

BUY
$25.01 - $42.4 $5.18 Million - $8.79 Million
207,208 New
207,208 $6.68 Million

Others Institutions Holding STAA

About STAAR SURGICAL CO


  • Ticker STAA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 48,038,300
  • Market Cap $1.4B
  • Description
  • STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...
More about STAA
Track This Portfolio

Track Tcw Group Inc Portfolio

Follow Tcw Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcw Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Tcw Group Inc with notifications on news.